Treatment
-
The Right DoseResearchers want to find out when cancer patients can benefit from receiving lower doses of drugs or radiation, shortening treatment or skipping certain treatments altogether.
by Kate Yandell
-
Focusing on Proton TherapyProton therapy, an alternative to standard radiation therapy, is safe and effective. But evidence is lacking that it's always a better option than standard radiation, and some insurers balk at the higher price tag.
by Sue Rochman
-
Forward Look
Concerns Raised About MRI Contrast DyeSome patients report unusual side effects after scans.
by Stephen Ornes
-
Forward Look
Pediatric Leukemia Treatments Are Not Just for KidsStudy supports using these regimens for teens and young adults.
by Bradley Jones
-
When a Top-Ranked Cancer Center Comes to a Hospital Near YouResearch shows prominent cancer hospitals have different surgical outcomes than their affiliates.
by Marci A. Landsmann
-
The Week in Cancer News: May 3Prospective CRISPR application targets cancer directly, HER2 testing accessibility poor in many countries.
by Bradley Jones
-
PARP Inhibitors in Pancreatic CancerDrugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.
by Kate Yandell
-
The Crowded Field of Checkpoint InhibitorsDrug developers behind currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.
by Kate Yandell
-
Drug Costs and Cancer CareExperts discuss the value of cancer treatments in a climate of rising drug prices.
by Kevin McLaughlin
-
What Is Hyper-Progression?Some researchers believe that immunotherapy occasionally causes cancer to grow faster, a phenomenon dubbed hyper-progression.
by Kate Yandell
